Soleus Capital Management, L.P. Eton Pharmaceuticals, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 285,000 shares of ETON stock, worth $5.72 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
285,000Holding current value
$5.72 Million% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
86Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$57.4 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$40.7 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$26.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$23.6 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$11.9 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $507M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...